References
- Gallagher RM, Moore P, Chemoff I. The reliability of depression diagnosis in chronic low back pain. A pilot study. Gen Hosp Psychiatry 1995; 17: 399–413.
- Von Korff M, Sirman G. The relationship between pain and depression. Br J Psychiatry 1996; 30 (Suppl): 101–108.
- Von Korff M, Le Resche L, Dworkin SF. First onset of common pain symptoms: a prospective study of depression as a risk factor. Pain 1993; 55: 251–258.
- Gershon S. Chronic pain: hypothesized mechanism and rationale for treatment. Neuropsychobiology 1986; 15 (Suppl 1): 22–27.
- Tulloch IF, Johnson AM. The pharmacologic profile of paroxetine, a new selective serotonin reuptake inhibitor. J CIM Psychiatry 1992; 53: 7–12.
- Dunner DL, Dunbar GC. Optimal dose regimen for paroxetine. J CIM Psychiatry 1992; 53: 21–26.
- Fava M, Davidson KG. Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Am 1996; 19: 179–200.
- Bergeron R, Blier P. Cisapride for the treatment of nausea produced by selective serotonin reuptake inhibitors. Am J Psychiatry 1994; 151: 1084–1086.
- Gureje O. Treating chronic pain in the context of comorbid depression. Pain 2008; 134: 3–4.
- Peroutka SJ, Sleight AJ, McCarthy BG et al. The clinical utility of pharmacological agents that act at serotonin receptors. J Neuropsychiatry Clin Neurosci 1989; 1: 253–262.
- Colpaert FC, Tarayre JP, Koek W et al. Large-amplitude 5-HT1, receptor activation: a new mechanism of profound, central analgesia. Neuropharmacology 2002; 43: 945–958.
- Duman EN, Kesim M, Kadioglu M et al. Possible involvement of opioidergic and serotonergic mechanisms in antinociceptive effect of paroxetine in acute pain. J Pharmacol Sci 2004; 94: 161–165.
- McQuay HJ, Tramer M, Nye BA et al. A systematic review of antidepressants in neuropathic pain. Pain 1996; 68: 217–227.
- Sawynok J, Esser MJ, Reid AR. Antidepressants as analgesics: an overview of central and peripheral mechanisms of action. J Psychiatry Neurosci 2001; 26: 21–29.